logo
Science Portal
Copyright © Médecins Sans Frontières
v2.1.5153.produseast1
About MSF Science Portal
About
Contact Us
Frequently Asked Questions (FAQs)
Privacy Policy
Terms of Use
Copyright © Médecins Sans Frontières
v2.1.5153.produseast1
Showing 1 - 20 of 29 Items
Showing 1 - 20 of 29 Items
Sort By: Relevance
  • Newest to oldest
  • Oldest to newest
  • Relevance
Journal Article
|
Research

Prevalence of hepatitis C virus seropositivity and active infection in a Rohingya refugee population in Cox's Bazar camps, Bangladesh: a cross-sectional study

Schramm B, Ashakin KA, Firuz W, Hadiuzzaman M, Ben-Farhat J,  et al.
2025-04-01 • Lancet Gastroenterology and Hepatology
2025-04-01 • Lancet Gastroenterology and Hepatology
Conference Material
|
Video

A concern for large-scale treatment access: High prevalence of active HCV infection among forcibly displaced Myanmar nationals residing in camps, Cox’s Bazar, Bangladesh

Schramm B
2024-07-01 • Epicentre Scientific Day 2024
2024-07-01 • Epicentre Scientific Day 2024
Conference Material
|
Poster

Prevalence of active hepatitis C virus (HCV) infection and associated factors among forcibly displaced Myanmar nationals residing in camps, Cox’s Bazar, Bangladesh

Ashakin KA, Hadiuzzaman M, Firuz W, Rahman A, Ben-Farhat J,  et al.
2024-05-23 • Epicentre Scientific Day 2024
2024-05-23 • Epicentre Scientific Day 2024
Conference Material
|
Poster

Seasonal malaria chemoprevention coverage survey for children 3 months –8 years in Aweil, South Sudan, 2022

Akem TE, Schramm B, Akeen WW, Singh SN, Adimw M,  et al.
2024-05-23 • Epicentre Scientific Day 2024
2024-05-23 • Epicentre Scientific Day 2024
Conference Material
|
Abstract

A concern for large-scale treatment access: High prevalence of active HCV infection among forcibly displaced Myanmar Nationals residing in camps, Cox’s Bazar, Bangladesh

Schramm B, Hossain FN
2024-05-23 • Epicentre Scientific Day 2024
2024-05-23 • Epicentre Scientific Day 2024

BACKGROUND

Hepatitis C virus (HCV) is a major cause of liver diseases globally. Transmission is primarily bloodborne through unsafe injections or healthcare practices. Effective...

Conference Material
|
Abstract

A novel personal protective equipment for filovirus outbreaks: a usability study under simulated field conditions

Sterk E, Schramm B, Riccio E, Gabut M, Fontana L,  et al.
2024-05-16 • MSF Scientific Day International 2024
2024-05-16 • MSF Scientific Day International 2024
INTRODUCTION
The 2014 West Africa Ebola outbreak underlined inadequacies of current personal protective equipment (PPE), such as being uncomfortable and hot, causing excessive sweati...
Conference Material
|
Slide Presentation

A novel personal protective equipment for filovirus outbreaks a usability study under simulated field conditions

Sterk E, Schramm B, Riccio E, Gabut M, Fontana L,  et al.
2024-05-16 • MSF Scientific Day International 2024
2024-05-16 • MSF Scientific Day International 2024
Conference Material
|
Poster

Evaluation of a simplified model of care for chronic hepatitis C infection in Rohingya population in Ukhiya, Cox’s Bazar, Bangladesh

Firuz W, Ashakin KA, Schramm B, Camelique O, Duka M,  et al.
2024-05-16 • MSF Scientific Day International 2024
2024-05-16 • MSF Scientific Day International 2024
Conference Material
|
Poster

Diagnostic performance and feasibility of two new treatment decision algorithms for pulmonary tuberculosis in children: A diagnostic and mixed-methods multi-country study

Abdullah MB, Issa-Soumana A-M, Namulwana ML, Barry I, Fidelle Nyikayo L,  et al.
2024-05-03 • MSF Paediatric Days 2024
2024-05-03 • MSF Paediatric Days 2024
Technical Report
|
Evidence Brief

Prevalence of active HCV infection and associated risk factors among members of Forcibly Displaced Myanmar National (FDMN) Population residing in camps, Cox’s Bazar, Bangladesh

Schramm B, Ashakin KA
2023-11-01
2023-11-01
Journal Article
|
Research

Viral suppression and HIV-1 drug resistance 1 year after pragmatic transitioning to dolutegravir first-line therapy in Malawi: a prospective cohort study

Schramm B, Temfack E, Descamps D, Nicholas S, Peytavin G,  et al.
2022-08-01 • Lancet HIV
2022-08-01 • Lancet HIV
BACKGROUND
Many countries are now replacing non-nucleoside reverse transcriptase inhibitor (NNRTI)-based first-line antiretroviral therapy (ART) with a regimen containing tenofovir d...
Journal Article
|
Research

Tolerability and safety of artesunate-amodiaquine and artemether-lumefantrine fixed dose combinations for the treatment of uncomplicated Plasmodium falciparum malaria: two open-label, randomized trials in Nimba County, Liberia

Schramm B, Valeh P, Baudin E, Mazinda CS, Smith R,  et al.
2013-07-17 • Malaria Journal
2013-07-17 • Malaria Journal
BACKGROUND
Safety surveillance of widely used artemisinin-based combination therapy (ACT) is essential, but tolerability data in the over five years age group are largely anecdotal.<...
Journal Article
|
Research

MDR M. tuberculosis outbreak clone in Eswatini missed by Xpert has elevated bedaquiline resistance dated to the pre-treatment era

Beckert P, Sanchez-Padilla E, Merker M, Dreyer V, Kohl TA,  et al.
2020-11-25 • Genome Medicine
2020-11-25 • Genome Medicine
Background
Multidrug-resistant (MDR) Mycobacterium tuberculosis complex strains not detected by commercial molecular drug susceptibility testing (mDST) assays due to the RpoB I491F ...
Conference Material
|
Poster

Levels of pre-treatment HIV drug resistance in rural and urban settings, Mozambique

Carnimeo V, Fuentes S J, Pulido Tarquino IA, Vaz D, Molfino L,  et al.
2019-05-20 • MSF Scientific Days International 2019: Research
2019-05-20 • MSF Scientific Days International 2019: Research
Journal Article
|
Research

Polymorphisms in Plasmodium falciparum chloroquine resistance transporter and multidrug resistance 1 genes: parasite risk factors that affect treatment outcomes for P. falciparum malaria after artemether-lumefantrine and artesunate-amodiaquine

Venkatesan M, Gadalla NB, Stepniewska K, Dahal P, Nsanzabana C,  et al.
2014-07-21 • American Journal of Tropical Medicine and Hygiene
2014-07-21 • American Journal of Tropical Medicine and Hygiene
Adequate clinical and parasitologic cure by artemisinin combination therapies relies on the artemisinin component and the partner drug. Polymorphisms in the Plasmodium falciparum chloroq...
Journal Article
|
Short Report

High prevalence of NRTI and NNRTI drug resistance among ART-experienced, hospitalized inpatients

Bossard C, Schramm B, Wanjala S, Jain L, Mucinya G,  et al.
2021-04-01 • Journal of Acquired Immune Deficiency Syndromes (1999)
2021-04-01 • Journal of Acquired Immune Deficiency Syndromes (1999)
Journal Article
|
Research

Field evaluation of a simple fluorescence method for detection of viable Mycobacterium tuberculosis in sputum specimens during treatment follow-up

Schramm B, Hewison CCH, Bonte L, Jones W, Camelique O,  et al.
2012-05-30 • Journal of Clinical Microbiology
2012-05-30 • Journal of Clinical Microbiology
Simple tuberculosis (TB) treatment monitoring tools are needed. We assessed the performance of fluorescein-diacetate (FDA) smear microscopy for detection of viable Mycobacterium tubercul...
Journal Article
|
Research

Efficacy of artesunate-amodiaquine and artemether-lumefantrine fixed-dose combinations for the treatment of uncomplicated Plasmodium falciparum malaria among children aged six to 59 months in Nimba County, Liberia: an open-label randomized non-inferiority trial

Schramm B, Valeh P, Baudin E, Mazinda CS, Smith R,  et al.
2013-07-17 • Malaria Journal
2013-07-17 • Malaria Journal
BACKGROUND
Prospective efficacy monitoring of anti-malarial treatments is imperative for timely detection of resistance development. The in vivo efficacy of artesunate-amodiaquine (A...
Journal Article
|
Research

Heterogeneous decrease in malaria prevalence in children over a six-year period in south-western Uganda

De Beaudrap P, Nabasumba C, Grandesso F, Turyakira E, Schramm B,  et al.
2011-05-18 • Malaria Journal
2011-05-18 • Malaria Journal
BACKGROUND
Malaria is a major public health problem, especially for children. However, recent reports suggest a decline in the malaria burden. The aim of this study was to assess the...
Journal Article
|
Research

Selection of Plasmodium falciparum pfcrt and pfmdr1 polymorphisms after treatment with artesunate-amodiaquine fixed dose combination or artemether-lumefantrine in Liberia

Otienoburu SD, Maiga-Ascofare O, Schramm B, Jullien V, Jones JJ,  et al.
2016-09-05 • Malaria Journal
2016-09-05 • Malaria Journal
BACKGROUND
Plasmodium falciparum uncomplicated malaria can successfully be treated with an artemisinin-based combination therapy (ACT). However resistance is spreading to the differe...